25 employees
Neuro42 is developing and commercializing advanced MRI technology for diagnosis and image-guided interventions.
2020
$6.5M
from 3 investors over 3 rounds
neuro42 raised $5M on September 28, 2023
Investors: National Institute of Neurological Disorders and Stroke (NINDS)
neuro42 raised $6.5M on July 27, 2021
Investors: ShangBay Capital and Zepp Labs, Inc.